glp-1 drugs market dynamics 2025 Receptor Agonist Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Glucagon-like Peptide 1 (GLP-1) Analogues
Description
It works by regulating blood sugar levels, which can reduce cravings for high-calorie foods and prevent overeating
As a result, doctors may misdiagnose someone with cancer they do not have, incorrectly label the stage of the cancer, and lead to unnecessary tests
GLP-1 may play an important role in the obesity market
Sienkiewicz E, Magkos F, Aronis KN, Brinkoetter M, Chamberland JP, Chou S, et al
And when it feels enjoyable, youre more likely to stick with it
In fact, Dapagliflozin (Farxiga/Forxiga) has now been approved specifically for chronic kidney disease even in patients without diabetes
